Immunicum AB News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

30.03.23	Mendus presents an update on the use of its DCOne platform to source high-quality NK cell therapies at the 8th Annual Innate Killer Summit (GlobeNewswire)
29.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
28.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
27.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
23.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
22.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
21.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
16.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
15.03.23	Mendus AB: Mendus to present positive interim data from the ALISON trial in ovarian cancer at the AACR Annual Meeting 2023 (GlobeNewswire)
13.03.23	Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
09.03.23	Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
07.03.23	Mendus AB: Mendus secures second shareholder loan from Van Herk Investments and reduces the number of outstanding convertible bonds with Negma Group (GlobeNewswire)
06.03.23	Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
06.03.23	Mendus AB: Mendus to participate in upcoming conferences in March 2023 (GlobeNewswire)
02.03.23	Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
28.02.23	Mendus AB: Change in number of shares and votes in Mendus AB (publ) (GlobeNewswire)
23.02.23	Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
17.02.23	Mendus AB: Mendus AB (publ) announces Q4 and year-end results 2022 (GlobeNewswire)
14.02.23	Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
09.02.23	Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
08.02.23	Mendus AB: Mendus announces request for conversion of convertible bonds by Negma Group (GlobeNewswire)
18.11.22	Mendus AB: Report from the Extraordinary General Meeting of Mendus AB (publ) on 18 November 2022 (GlobeNewswire)
11.11.22	Mendus AB: Mendus AB (publ) Interim Report July – September 2022 (GlobeNewswire)
10.11.22	Mendus AB: Mendus announces Nomination Committee for the 2023 Annual General Meeting (GlobeNewswire)
26.10.22	Mendus AB: Notice of extraordinary general meeting in Mendus AB (publ) (GlobeNewswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

CieFinRichemont	121.15	2.19 %	K V
Logitech Intl	72.20	1.66 %	K V
Lonza Grp	526.60	1.00 %	K V
Swiss Re	129.35	0.82 %	K V
UBS Group	28.35	0.18 %	K V
Givaudan	3’901.00	-0.81 %	K V
Swiss Life Hldg	725.40	-1.12 %	K V
Holcim	89.78	-1.12 %	K V
Novartis	91.93	-1.87 %	K V
Sonova Hldg	306.20	-1.89 %	K V

Nachrichten zu Immunicum AB

Aktien Top/Flop

Meistgelesene Nachrichten